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Plasmodium development withinAnophelesmosqui-
toes is a vulnerable step in the parasite transmission
cycle, and targeting this step represents a promising
strategy for malaria control. The thioester-containing
complement-like protein TEP1 and two leucine-rich
repeat (LRR) proteins, LRIM1 and APL1, have been
identified as major mosquito factors that regulate
parasite loads. Here, we show that LRIM1 and
APL1 are required for binding of TEP1 to parasites.
RNAi silencing of the LRR-encoding genes results
in deposition of TEP1 on Anopheles tissues, thereby
depleting TEP1 from circulation in the hemolymph
and impeding its binding to Plasmodium. LRIM1
and APL1 not only stabilize circulating TEP1, they
also stabilize each other prior to their interaction
with TEP1. Our results indicate that three major anti-
parasitic factors in mosquitoes jointly function as a
complement-like system in parasite killing, and they
reveal a role for LRR proteins as complement control
factors.
INTRODUCTION
Protozoan parasites of the Plasmodium genus persist and
amplify in vertebrate hosts during their asexual stage and
depend on mosquitoes for completion of their sexual cycle
and further transmission. Mosquitoes ingest gametocytes by
taking a blood meal on an infected vertebrate. After fertilization
of male and female gametes, the zygotes differentiate into motile
ookinetes that traverse the midgut epithelium to reach the basal
side. There they develop into oocysts that undergo multiple
rounds of cellular divisions, forming numerous sporozoites.Cell HMature oocysts rupture and release the sporozoites into the
hemolymph, the mosquito blood. Sporozoites migrate from the
midgut to the salivary glands and are transmitted to a new host
during the next mosquito bite (Sinden, 2002).
The development of Plasmodium in the mosquito is consider-
ably hindered by a powerful insect immune response. Major
parasite losses occur at the ookinete stage after its passage
through the midgut epithelium within the first 24 hr postinfection
(hpi) (Whitten et al., 2006). This antiparasitic defense has been
mostly analyzed in laboratory conditions with the rodent malaria
Plasmodium berghei as a model (Janse and Waters, 1995).
Recent reverse genetics studies identified several genes encod-
ing secreted proteins that crucially determine the outcome of
P. berghei development in Anopheles gambiae. Among them is
the complement-like glycoprotein TEP1 (Blandin et al., 2008).
TEP1 belongs to the family of thioester-containing proteins
that share sequence similarity with the vertebrate complement
factors C3/C4/C5 and a2-macroglobulins (Blandin and Leva-
shina, 2004). The vertebrate complement system comprises
around 35 serum and cell-surface molecules that interact in
a cascade, ultimately resulting in opsonization of pathogens
and in induction of inflammatory responses at the site of infec-
tion. It is triggered by recognition and binding of a series of circu-
lating factors to pathogen surfaces. These factors include anti-
bodies, mannan-binding lectins, and ficolins. The alternative
pathway does not require an initial recognition event and is
constitutively activated by a low-level hydrolysis of the comple-
ment factor C3 and its association with factor B. All pathways
trigger proteolytic cascades that converge upon the massive
activation of the central component C3 and generation of its
cleavage products that fulfill the major functions of the comple-
ment system: (1) binding of the larger proteolytic fragment C3b
to microbes initiates the assembly of the membrane attack
complex, which forms a pore in pathogen membranes and
causes their lysis; (2) further cleavage of C3b produces iC3b
that interacts with complement receptors and thus promotesost & Microbe 5, 273–284, March 19, 2009 ª2009 Elsevier Inc. 273
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iC3b, C3d, is recognized by another class of complement recep-
tors that activate B lymphocytes; and finally, (4) soluble anaphy-
latoxins C3a, C4a, and C5a, clipped off from the a chains of the
corresponding complement factors, cause inflammation and
recruitment of immune cells at the site of complement activation
(Lambris et al., 1999).
In A. gambiae, TEP1 is constitutively produced by hemocytes,
the mosquito blood cells, and is secreted into the hemolymph as
a full-length form (TEP1-F) of 160 kDa. Here, it is processed into
an 75 kDa N-terminal (TEP1-N) and an 85 kDa C-terminal
fragment (TEP1-C), containing the thioester bond. The three-
dimensional structure of TEP1 reveals a close structural
homology between TEP1 and the human complement factor
C3 (Baxter et al., 2007) and predicts that, like in C3, the two
chains of cleaved TEP1 should remain associated, forming
a single complex due to the interdigitation of their secondary
structure elements.
Similar to complement factors, TEP1 binds to the surface of
Gram-negative and Gram-positive bacteria. Inactivation of the
thioester by methylamine treatment abolishes binding of
TEP1-C and delays phagocytosis of bacteria. This is in sharp
contrast to the full-length TEP1, which binds bacteria in a
thioester-independent manner but is unable to promote uptake
of bacteria (Levashina et al., 2001). In adult mosquitoes, knock-
down of TEP1 dramatically impairs phagocytosis of Escherichia
coli and Staphylococcus aureus, and therefore TEP1 plays a very
similar role to C3 (Moita et al., 2005).
As is the case for bacteria, TEP1 is detected on the surface
of invading ookinetes by immunofluorescence analysis of
P. berghei-infected midguts using antibodies directed against
TEP1-C. Furthermore, knockdown of TEP1 by injection of
specific dsRNA into the mosquitoes increases by 3- to 5-fold
the burden of developing oocysts (Blandin et al., 2004). TEP1
also mediates killing of the most deadly human malaria parasite,
P. falciparum (Dong et al., 2006), demonstrating that parasite
elimination by the complement-like protein is a conserved
component of the mosquito immune responses against rodent
and human plasmodia. TEP1 gene is exceptionally polymorphic,
especially in the thioester domain and in the regions surrounding
it. Two highly divergent alleles, TEP1s and TEP1r, were identified
in laboratory-selected susceptible and refractory mosquito lines,
respectively (Blandin et al., 2004; Collins et al., 1986). Recent
evolutionary studies performed on mosquitoes collected in three
sites in Africa suggest that these alleles resulted from a series of
gene conversion events involving TEP5 and TEP6 genes, which
are clustered with TEP1 on the left arm of the third chromosome
(Christophides et al., 2002; Obbard et al., 2008). To elucidate
how TEP1 polymorphism modulates the efficiency of parasite
killing in the refractory line requires a better understanding of
the sequence of molecular events, starting with TEP1 activation
and binding to Plasmodium and leading to parasite killing. We
postulated that activity of TEP1 is regulated by partner mole-
cules and set out to identify them.
In addition to TEP1, two leucine-rich repeat (LRR) proteins,
LRIM1 (leucine-rich repeat immune protein 1) and APL1 (Anoph-
eles Plasmodium-responsive leucine-rich repeat 1), have been
shown to strongly affect P. berghei development on the
mosquito midgut (Blandin et al., 2004; Osta et al., 2004; Riehle274 Cell Host & Microbe 5, 273–284, March 19, 2009 ª2009 Elsevieret al., 2006). Their potency in the antiparasitic response is illus-
trated by the increase in parasite survival following knockdown
by RNAi of the respective genes. APL1 maps to the locus that
controls resistance to human malaria parasites in African
mosquito populations and is believed to be one of the major
resistance factors in natural infections (Niare et al., 2002; Riehle
et al., 2007). LRR proteins are involved in protein-protein interac-
tions (Kobe and Kajava, 2001), and their important roles in innate
immunity are well documented in plants and mammals (Nurn-
berger et al., 2004). In P. berghei infections, the knockdown
phenotypes of LRIM1 and APL1 are very similar to that of
TEP1: on average, all three result in a 3-fold increase in parasite
loads in the mosquito midgut. Moreover, the expression of TEP1
and LRIM1 is regulated by the Cactus/Rel1 signaling cassette,
further supporting the hypothesis that these genes might
function in the same pathway (Frolet et al., 2006). We therefore
investigated molecular interactions between TEP1, LRIM1, and
APL1 using functional, cell biology, and immunobiochemical
approaches.
Here, we report that proteolytic cleavage of TEP1 in the hemo-
lymph is crucial for its maturation into a form that is maintained in
circulation by a multiprotein complex involving LRIM1 and APL1.
Knockdown of either of the two LRR-encoding genes depletes
mature TEP1 from the hemolymph, probably as a result of its
misguided binding to self-tissues, and abolishes TEP1 binding
to P. berghei. Our results demonstrate that the expression and
function of three major antiparasitic factors are coordinated
in a complement-like cascade that represents a crucial compo-
nent of Plasmodium killing, and that LRR proteins function as
complement-control proteins in the mosquito.
RESULTS
Coregulation of TEP1, LRIM1, and APL1 Expression
by the Cactus/Rel1 Signaling Module
Expression of genes involved in the same functional pathways is
often coregulated at the transcriptional level. We have previously
reported that basal levels of expression of TEP1 and LRIM1, but
not of APL1, are regulated by the NF-kB factor Rel1 and its inhib-
itor, Cactus (Frolet et al., 2006). Given strong functional indica-
tions that these three genes might function in the same pathway,
we re-examined the APL1 expression pattern based on the anal-
ysis of APL1 clones identified in a cDNA library of mosquito
hemocytes and midguts (S. Wyder, S.-H. Shiao, S.A.B., C. Kap-
pler, C.F., N. Baldeck, J.A.H., and E.A.L., unpublished data).
Four cDNA clones corresponded to APL1 as it was formerly
annotated by the Ensembl database (ENSANGT00000014508)
(Riehle et al., 2006). Sequence analysis showed that this initial
prediction for APL1 comprised at least two distinct genes. Two
clones (4CE12 and 63BH09) represent one gene, annotated
now as AGAP007037. Expression of this gene was tested previ-
ously (Frolet et al., 2006) and was not affected by dsAPL1 knock-
down. Clones 104AF09 and 11CC06 encode the APL1 gene
(AGAP007033) against which dsRNA had been designed (Riehle
et al., 2006). We re-examined the expression of APL1 in Cactus-
and Rel1-deficient backgrounds using the updated sequence
information. A 3-fold boost of APL1 expression was observed
4 days after dsCactus injection compared to the control dslacZ
(Figure 1A). Simultaneous silencing of Cactus with Rel1 rescuedInc.
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Expression by the Cactus/Rel1 Cassette
(A) Transcriptional profiling of APL1 in dsRNA-
treated mosquitoes by quantitative real-time
PCR. Mosquitoes were injected with dsRNA and
infected with P. berghei 4 days later. Relative
transcript levels were assessed before dsRNA
injection (96 hr) and at 0, 18, 24, and 48 hr post-
infection (ten mosquitoes per data set). Data was
normalized using ribosomal protein transcript
RpL19, and fold induction was calculated relative
to the APL1 expression levels before dsRNA
injection. Mean values ± SEM of two or three
independent biological experiments are shown.
(B) Immunoblotting of hemolymph collected from
15 dslacZ- and dsCactus-treated mosquitoes
4 days after injection using anti-LRIM1 and anti-
APL1 antibodies. Antibody against secreted
PPO2 was used as a loading control.the effect of Cactus knockdown, demonstrating that the Cactus/
Rel1 cassette regulates the levels of expression of APL1. Inter-
estingly, after P. berghei infection, the pattern of expression of
APL1 was similar to that of TEP1 and LRIM1 (Blandin et al.,
2004; Frolet et al., 2006), with a peak of expression at 24 hpi.
We raised rabbit polyclonal antibodies against LRIM1 and APL1
to monitor their expression at the protein level. Using these anti-
bodies for immunoblotting analysis, signals corresponding to
secreted LRIM1 (60 kDa) and APL1 (100 kDa) were detected
in hemolymph extracts. Importantly, a prominent increase in the
intensity of LRIM1 and APL1 signals, as compared to dslacZ
controls, was observed in hemolymph extracts from Cactus
knockdown mosquitoes 4 days after dsRNA injection (Figure 1B).
Thus, expression of TEP1, LRIM1, and APL1 is coregulated by
the Rel1/Cactus signaling module. Our results onAPL1 expression
are consistent witha recent independent report (Riehleetal., 2008).
LRIM1 and APL1 Are Required for TEP1 Binding
to Ookinetes
We next examined whether the function of TEP1 is preserved in
LRIM1- and APL1-depleted backgrounds by monitoring the effi-
ciency of TEP1 binding to ookinetes. To this aim, we silenced
LRIM1 and APL1 by injection of dsRNA. Injection of dslacZ
served as a negative control for the effect of injury and dsRNA
treatment. Four days after injection, mosquitoes were infected
with a GFP-expressing P. berghei strain by taking a blood meal
on an infected mouse (Franke-Fayard et al., 2004). TEP1 binding
to ookinetes was monitored 18 and 24 hpi by immunostaining of
midguts with polyclonal antibody raised against a C-terminal
portion of TEP1 (Levashina et al., 2001). As previously reported
for dslacZ-injected control mosquitoes, approximately 5% and
30%–50% of parasites displayed TEP1 staining on their surface
at 18 and 24 hpi, respectively (Frolet et al., 2006). Most TEP1-
positive parasites no longer expressed GFP and were consid-
ered dead (Figure 2A). Remarkably, LRIM1 and APL1 single
and LRIM1/APL1 double knockdowns completely abolished
TEP1 binding to parasites, demonstrating that LRR proteins
are required for TEP1 function.
The striking absence of TEP1 on the parasite surface in the
LRIM1- and/or APL1-depleted mosquitoes could result from
reduced TEP1 expression. To test this, the presence of TEP1Cell Hprotein in hemocytes was examined at 18 hpi. A signal corre-
sponding to TEP1 was detected in all tested knockdowns
(Figure 2B), suggesting that dsLRIM1 and/or dsAPL1 do not
affect TEP1 expression at the protein level. These results were
independently confirmed at the transcriptional level by quantita-
tive real-time PCR (Figure 2C). Depletion of LRIM1 or APL1 did
not decrease levels of TEP1 expression at 48 hr after dsRNA
injection, and a consistent albeit modest increase in TEP1
expression was detected in dsLRIM1/dsAPL1 double knock-
down mosquitoes. We conclude that LRIM1 and APL1 do not
regulate TEP1 expression, but its posttranslational activity.
LRIM1 and APL1 Stabilize the Circulating Cleaved TEP1
Proteolytic activation plays a crucial role in the function of
complement proteins (Lachmann and Hughes-Jones, 1984). To
examine whether LRIM1 and APL1 affect TEP1 cleavage after
Plasmodium infection, protein extracts of mosquito hemolymph
were analyzed by immunoblotting with our existing C-terminal
polyclonal antibodies (Levashina et al., 2001) and a specific
monoclonal antibody raised against a peptide from the
N-terminal portion of TEP1s. In these experiments, we included
an additional negative control by injecting dsRNA targeting
another LRR-encoding gene, APL2, whose silencing has no
effect on parasite development (Riehle et al., 2006). In all tested
knockdowns, the signal corresponding to the full-length form of
TEP1 (TEP1-F) was not significantly affected (Figure 3A). In
contrast, silencing of LRIM1 and APL1, but not of APL2, severely
reduced the signal corresponding to TEP1-C in hemolymph
extracts. Similar results were obtained for TEP1-N, indicating
that depletion of LRR proteins interferes either with TEP1
cleavage or with the stability of its processed forms. We also
noted that the phenotype of concomitant silencing of LRIM1
and APL1 was comparable to single knockdowns (data not
shown). The effect of LRIM1 or APL1 depletion on the cleaved
forms of TEP1 was infection independent, as signals for both
cleavage products were reduced before and after Plasmodium
infection. Strikingly, when protein extracts of whole bodies
were examined, all forms (full-length, TEP1-N, and TEP1-C)
were detected in control and LRR-depleted mosquitoes
(Figure 3B). In these samples, antibodies against TEP1-C were
more efficient in recognizing TEP1-C than the full-length form,ost & Microbe 5, 273–284, March 19, 2009 ª2009 Elsevier Inc. 275
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form and were less efficient in recognizing TEP1-N. Altogether,
these results suggest that cleavage of TEP1 is independent of
LRIM1 and APL1 function. Instead, the LRR proteins appear to
maintain the cleaved form of TEP1 in circulation, as in their
absence both TEP1-N and TEP1-C forms, but not the full-length
form, are depleted from the hemolymph.
We next sought to identify the site of deposition of TEP1
cleavage products detected in whole-body mosquito extracts.
To this end, we performed immunofluorescence analysis of
mosquito whole-body preparations using the anti-TEP1-C and
anti-TEP1-N antibodies, which allowed us to follow the fate of
Figure 2. Effect of LRIM1 and APL1 Silencing on TEP1 Binding
to P. berghei and on TEP1 Levels of Expression
(A and B) Immunofluorescence analysis of midguts (A) and abdominal
epidermis with attached hemocytes (B) performed with TEP1-C-specific anti-
body (red). Mosquitoes were injected with dsRNA, infected with P. berghei-
GFP (green) 3 days later, and dissected 18 and 24 hr postinfection. Nuclei
are stained with DAPI (blue). Images are projections of six to twelve 1.2 mm
spaced optical sections. Basal membrane was excluded from the sections.
Scale bar: 5 mm.
(C) Transcriptional levels of TEP1 in dsRNA-treated mosquitoes assessed by
quantitative real-time PCR 48 hr after dsRNA injection (ten mosquitoes per
data set). Each star represents the levels of TEP1 transcripts normalized using
ribosomal protein geneRpL19 and expressed as a fold induction relative to the
levels of TEP1 in the dslacZ-injected control. Results of three independent bio-
logical experiments are presented.276 Cell Host & Microbe 5, 273–284, March 19, 2009 ª2009 Elseviereach of the two moieties of the cleaved TEP1. Unlike control
mosquitoes displaying low background fluorescence, colocali-
zation of TEP1-N- and TEP1-C-specific signals was detected
on the midgut and on the abdominal epidermis of LRIM1- and
APL1-depleted mosquitoes (Figures 3C and 3D). As LRIM1
and APL1 knockdowns did not affect the presence of full-length
TEP1 in circulation (Figure 3A), we interpret the colocalization of
the two signals as the deposition of the cleaved form of TEP1 on
mosquito tissues. TEP1 was observed on self-tissues for at least
8 days with no adverse effects on mosquito survival (data not
shown).
We extended this analysis to TEP1 binding to parasites.
Coimmunostaining experiments with the anti-TEP1-N and anti-
TEP1-C antibodies revealed a perfect colocalization of TEP1-N
and TEP1-C signals on the surface of dead and dying parasites
at 24 hpi (Figure 3E). Taken together, our results demonstrate
that the full-length form of TEP1, TEP1-F, does not bind to para-
sites in LRR-depleted mosquitoes. Thus, either LRR proteins are
required for TEP1-F binding to parasites, or it is the cleaved form
of TEP1 that decorates invading parasites.
Proteolytic Cleavage of Recombinant TEP1 In Vitro
Produces a Two-Chain Molecule
Our observations of colocalization of the immunofluorescence
signals for N- and C-terminal fragments of TEP1 on ookinetes
and self-tissues, together with our previous structural analysis
(Baxter et al., 2007), suggest that proteolytic cleavage of circu-
lating TEP1 in vivo does not lead to dissociation of the two frag-
ments, but rather converts the full-length form into a two-chain
molecule. To test this prediction, we characterized TEP1 after
proteolytic cleavage in vitro using protein from the refractory
L3-5 mosquito strain that was recombinantly produced incorpo-
rating a C-terminal histidine-tag (TEP1r-63His) and purified to
homogeneity as previously described (Baxter et al., 2007). We
have previously shown by protein sequencing that trypsin
processes TEP1 after residue 601 (Baxter et al., 2007),
producing the same-sized N-terminal (75 kDa) and C-terminal
(85 kDa) fragments as observed for TEP1 in vivo (Levashina
et al., 2001). Therefore, we performed limited trypsinolysis on
purified recombinant TEP1r-63His and compared the full-length
and cleaved forms by chromatography. The N- and C-terminal
fragments comigrated in size-exclusion chromatography with
the same apparent molecular weight as full-length TEP1r-
63His (Figure 4A), and both fragments eluted at the same ionic
strength in cation-exchange chromatography (Figure 4B). These
results indicate that both chains of TEP1 remain associated after
cleavage in vitro.
The protease responsible for TEP1 cleavage in vivo has not yet
been identified and may have different substrate specificity to
trypsin, which cleaves after basic residues. Structural analysis
predicted that the TEP1 protease-sensitive region spans resi-
dues 580–601 and contains multiple cleavage sites for a variety
of proteases. Therefore, we performed limited proteolysis of
TEP1r-63His with chymotrypsin (cleaving after aromatic resi-
dues), elastase (cleaving after small hydrophobic residues),
and S. aureus V8 protease (cleaving after acidic residues) and
analyzed the results by SDS-PAGE. TEP1r-63His was readily
cleaved by trypsin, chymotrypsin, and elastase (Figure 4C,
data not shown for elastase), generating N- and C-terminalInc.
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Complement-like System in Mosquito ImmunityFigure 3. Effect of LRIM1 and APL1 Depletion on TEP1 Maturation and Binding Properties
(A) Immunoblotting of hemolymph collected from noninjected (NI) and dsRNA-treated mosquitoes 24 hr after injection and 18 and 24 hr postinfection with
P. berghei (15 mosquitoes per group). The full form (TEP1-F) and the C-terminal cleaved form (TEP1-C) of TEP1 are revealed on the blots by TEP1-C-specific
antibodies. TEP1-F and the N-terminal cleaved form (TEP1-N) of the protein are revealed by TEP1-N specific antibodies.
(B) Immunoblotting of whole-body protein extracts using TEP1-C- and TEP1-N-specific antibodies. Whole-body extracts were prepared by homogenization of
tissue from ten mosquitoes collected 24 hr after dsRNA injection. In (A) and (B), antibody against secreted PPO2 was used as a loading control.
(C and D) Immunostaining of midguts (C) and abdominal epidermis (D). TEP1 signal corresponding to the TEP1-N-specific antibody is shown in red and staining
with the TEP1-C-specific antibody in green. Mosquitoes were dissected 24 hr after dsRNA injection. Nuclei are stained with DAPI (blue). Images are projections of
four to six 1.2 mm spaced optical sections. Note that in contrast to the images shown in Figures 2A and 3E, basal membrane is included in the reconstruction of
optical sections. Scale bar: 5 mm.
(E) Colocalization of TEP1-N and TEP1-C on ookinetes. Immunostaining of infected midguts with TEP1-N (red)- and TEP1-C (green)-specific antibodies. Mosqui-
toes were infected with P. berghei-GFP (white), and midguts were dissected 24 hpi. Nuclei are stained with DAPI (blue). Images are projections of twelve 1.2 mm
spaced optical sections. Scale bar: 5 mm.fragments that were stable in an excess of these two proteases
and sized similarly to those seen in vivo. In contrast, V8 protease
did not cleave TEP1r-63His at low concentrations and, in
excess, led to fragments distinct from those observed in vivo,Cell Hdespite the presence of an acidic residue (Glu585) within the pre-
dicted range of residues 580–601. Thus we predict that, like
trypsin, the endogenous protease(s) for TEP1 cleave(s) within
residues 585–601 of the protease-sensitive region and that, inost & Microbe 5, 273–284, March 19, 2009 ª2009 Elsevier Inc. 277
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Figure 4. Proteolytic Cleavage of Recombinant TEP1 In Vitro and Biochemical Properties of the Resulting Two-Chain Molecule
(A) Purification of full-length and trypsinized (cleaved) TEP1r-63His by size-exclusion chromatography. Inset shows Coomassie-stained SDS-PAGE of the loaded
protein for TEP1r-63His, cleaved TEP1r-63His, and five peak fractions (0.5 ml each) for cleaved TEP1r-63His.
(B) Purification of trypsinized TEP1r-63His by cation-exchange chromatography. The solid line plot represents relative absorbance (left axis) and the dashed line
conductivity (right axis). Inset shows Coomassie-stained SDS-PAGE of protein before and after limited trypsinolysis and five peak fractions (1 ml each).
(C) Limited proteolysis of purified TEP1r-63His. Coomassie-stained SDS-PAGE of TEP1r-63His treated with trypsin, chymotrypsin, and S. aureus V8 protease;
gradient shows decrease in protease concentrations from 1:1000 to 1:1 weight protein:protease ratio.
(D) Thioester assay for soluble TEP1r-63His, stored at room temperature for 54 days.
(E) Thioester assay for purified TEP1r-63His. Coomassie-stained SDS-PAGE of control () and heat-exposed test (+) samples for TEP1r-63His, treated with
methylamine (MeNH2) at pH 9.5 and following limited trypsinolysis. Methylamine treatment inactivates the thioester, thereby preventing the autolytic cleavage
of full-length TEP1r-63His. An active thioester is retained in trypsinized TEP1r-63His, evidenced by autolysis of the 85 kDa C-terminal fragment into 55 kDa (resi-
dues 841–1325) and 30 kDa (residues 601–840) fragments. Molecular weight markers for (C)–(E) are BenchMark unstained protein ladder (Invitrogen).this respect, trypsinized TEP1 mimics the in vivo cleaved form.
The general proteolytic susceptibility within this region is more
similar to a2-macroglobulin than to complement factors.
Proteolysis of TEP1 may lead to (1) maturation (for instance,
intracellular processing of complement factors), which leaves
the thioester bond intact, or (2) activation (for instance, cleavage
of the bait region of a2-macroglobulin), causing dramatic struc-
tural changes and rapid reaction of the thioester. Proteolysis of
complement factor C3 by either its native convertase or by
trypsin leads to rapid (<1 s) activation to C3b (Sim et al., 1981).
To determine if cleavage of TEP1r-63His in the protease-sensi-
tive region results in its activation, we assayed the presence of an
intact thioester bond in the full-length and cleaved forms by heat-
induced autolytic cleavage of denatured protein (Sim and Sim,
1981). We had shown that, upon heating, the intact protein
(160 kDa) was cleaved at Gln841 of the full-length protein, gener-
ating an N-terminal (105 kDa) and a C-terminal (55 kDa) fragment278 Cell Host & Microbe 5, 273–284, March 19, 2009 ª2009 Elsevie(Levashina et al., 2001). As a control, we inactivated the thioester
bond with methylamine at alkaline pH. Purified full-length
TEP1r-63His readily underwent autolytic cleavage after heat
treatment, demonstrating that it contained an intact thioester
bond (Figure 4D). Methylamine treatment efficiently inactivated
the thioester bond in purified TEP1r-63His, as evidenced by
absence of autolytic cleavage. Binding of methylamine to
Gln841 was confirmed by mass spectrometry (data not shown).
Upon limited proteolysis with trypsin, however, fragmentation of
the C-terminal 85 kDa band was still observed upon heating,
indicating the presence of an intact thioester. Hence, cleavage
of TEP1r-63His within the protease-sensitive region is not suffi-
cient to cause spontaneous activation of the thioester bond.
Together, our in vitro results support a model whereby proteo-
lytic cleavage of TEP1 in vivo generates a mature two-chain
molecule that retains the capacity for covalent attachment to
a substrate.r Inc.
Figure 5. Expression and Protein Profiles of LRIM1 and APL1 in Different Knockdown Backgrounds
(A) Immunoblotting of hemolymph samples collected from 15 dsRNA-injected mosquitoes 24 hr postinjection. The hemolymph profiles of LRIM1 and APL1 are
presented. Antibody against secreted PPO2 was used as a loading control.
(B) Transcriptional profiling of LRIM1 and APL1 in dsRNA-treated mosquitoes by quantitative real-time PCR 48 hr after dsRNA injection (ten mosquitoes per data
set). Each star represents transcript levels of the analyzed gene normalized to the levels of the ribosomal protein transcriptRpL19 and expressed as fold induction
relative to the levels of each gene in the dslacZ-injected control. Results of three independent biological experiments are plotted.
(C) Immunoblotting of hemolymph extracts collected from 15 mosquitoes 4 days after dsRNA injection. The hemolymph profiles of TEP1, LRIM1, and APL1 are
shown. Note that the same membranes were used to probe the antibodies. Antibody against secreted PPO2 was used as a loading control.
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to Interaction with TEP1
Expression of both LRIM1 and APL1 is required to prevent depo-
sition of mature TEP1 on self-tissues after proteolytic cleavage,
pointing out that the functions of these two genes might be
tightly linked. We monitored by immunoblotting the presence
of LRIM1 and APL1 in the hemolymph extracts of a series of
knockdown backgrounds using the polyclonal antibodies raised
against both proteins (Figure 5A). Knockdown of LRIM1 and
APL1 efficiently depleted the corresponding signals, indicating
that gene silencing was successful. Unexpectedly, knockdown
of APL1 caused complete disappearance of the signal corre-
sponding to LRIM1 and, reciprocally, knockdown of LRIM1 elim-
inated APL1. To eliminate the possibility of RNAi-induced cross-
silencing, we gauged levels of LRIM1 and APL1 expression after
dsRNA injection by quantitative real-time PCR. No significant
differences were observed in the LRIM1 transcript levels in
APL1-deficient mosquitoes compared to the control dslacZ.
Similarly, the transcription of APL1 in dsLRIM1-injected mosqui-
toes was not notably altered (Figure 5B), ruling out the possibility
of RNAi cross-silencing. Our findings suggest that the two LRR
proteins are unstable individually and require the presence of
each other to persist in circulation, perhaps through the forma-
tion of a complex. These results are in line with striking similari-
ties between single and double knockdown phenotypes of the
LRR-encoding genes. Indeed, a single knockdown of either
LRIM1 or APL1 is sufficient to entirely remove both proteinsCell Hfrom circulation and therefore is phenotypically equivalent to
a double knockdown.
We next examined whether persistence of LRR proteins in the
hemolymph depends on TEP1. Both LRIM1 and APL1 were de-
tected in the hemolymph of TEP1-knockdown mosquitoes;
therefore, the stability of LRRs does not require TEP1 presence
(Figure 5C).
LRIM1 and APL1 Interact with TEP1
To determine whether the two LRR proteins may interact with
TEP1, we carried out coimmunoprecipitation (co-IP) experi-
ments. In mosquitoes, co-IP of hemolymph proteins is often
hampered by limited quantities of available biological material.
To bypass this constraint, we directly injected adult females
with purified full-length TEP1r-63His (Figure 6A). PBS-injected
mosquitoes served as a negative control, as all our attempts to
use unrelated 63His-tagged proteins were unsuccessful (failure
to immunoprecipitate the exogenous protein). TEP1-interacting
proteins are expected to bind the injected TEP1r-63His fusion
protein and to be pulled down with it. Protein extracts of injected
mosquitoes were prepared 3 hr after injection, and IP was per-
formed with anti-63His-tag antibody. Immunoprecipitates
and post-IP samples were analyzed by immunoblotting using
antibodies against the 63His-tag, TEP1-C, TEP1-N, LRIM1,
APL1, and pro-phenoloxidase 2 (PPO2) (Figure 6B). TEP1r-
63His was rapidly processed in the mosquito body cavity, and
its C-terminal cleaved form was detected in the precipitatesost & Microbe 5, 273–284, March 19, 2009 ª2009 Elsevier Inc. 279
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Complement-like System in Mosquito ImmunityFigure 6. Coimmunoprecipitation Analysis of TEP1, LRIM1, and APL1 Interactions
(A) Experimental setup. Mosquitoes were injected with either recombinant TEP1r-63His dissolved in PBS or with PBS only and collected 3 hr later for tissue
homogenization and lysis. Injected TEP1r-63His was immunoprecipitated with anti-63His-tag antibody.
(B) Immunoblotting analysis of postimmunoprecipitation lysate (post-IP) and precipitates (co-IP). Hemolymph and TEP1r-63His protein served as a positive
control. The membrane was probed with antibodies specific for the 63His-tag, TEP1-C, TEP1-N, LRIM1, APL1, and PPO2. *, heavy chains of the mouse
anti-63His-tag antibody recognized by secondary anti-mouse IgG antibody or crossreacting anti-rabbit IgG antibody; **, nonspecific signals observed in
post-IP and co-IP samples.from TEP1r-63His-injected but not PBS-treated mosquitoes.
The full form of the fusion protein was not retained by the antibody
and remained in the post-IP supernatant. Importantly, a signal
corresponding to LRIM1 and APL1 was revealed in the precipi-
tates from TEP1r-63His-injected mosquitoes but was absent in
control samples, demonstrating that the two LRR proteins coim-
munoprecipitated with TEP1-C in our experimental settings. We
next investigated whether endogenous TEP1 was also precipi-
tated. To distinguish between the recombinant and endogenous
TEP1, we made use of the TEP1-N monoclonal antibody, which
specifically recognizes endogenous TEP1s from the G3 mosqui-
toes but not TEP1r from the L3-5 strain or recombinant TEP1r-
63His (Figures 6B and S1). Endogenous TEP1-N was detected
in the immunoprecipitate, suggesting that in addition to LRIM1
and APL1, the protein complex contains more than one TEP1
molecule. As a control for the specificity of IP, we reprobed the
immunoblots with an antibody against PPO2, a hemolymph-
borne enzyme catalyzing melanization reaction in insects, which
we have used as a loading control throughout this study.
Although a clear PPO2-positive signal was detected in the
post-IP samples, it was not observed in the IP precipitates, indi-
cating that TEP1r-63His pull-down was specific. We conclude
that the stabilization of mature TEP1 in the hemolymph requires280 Cell Host & Microbe 5, 273–284, March 19, 2009 ª2009 Elseviera multiprotein interaction involving several TEP1 molecules and
at least two LRR proteins, LRIM1 and APL1.
DISCUSSION
The ability to detect and swiftly destroy invading pathogens is of
paramount importance to any living organism. Several factors
have been identified in mosquitoes that are required for efficient
Plasmodium elimination. However, how the functions of these
factors converge to ensure parasite killing has remained unclear.
Here, we report that binding of TEP1 to the parasite surface,
a crucial event in Plasmodium killing, requires the coordinated
action of LRIM1 and APL1. Silencing of either of the two LRR-
encoding genes leads to deposition of cleaved TEP1 on self-
tissues, resulting in depletion of the protein from circulation
and to the abolishment of TEP1 binding to ookinetes and their
subsequent lysis during Plasmodium infection. Therefore, the
high oocyst survival reported in LRIM1- and APL1-depleted
mosquitoes (Osta et al., 2004; Riehle et al., 2006) can be predom-
inantly if not completely attributed to the malfunction of TEP1.
TEP1 shares significant sequence similarity and structural
organization with the mammalian complement factor C3 (Baxter
et al., 2007; Levashina et al., 2001). In mammals, intracellularInc.
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secreted into the blood. Further proteolytic cleavage releases
the N-terminal fragment of the a chain, C3a, thus bringing about
major structural changes and causing the binding of C3b to
nearby pathogen surfaces. The soluble C3a anaphylatoxin
signals to immune cells to attract them to the site of C3 activa-
tion. In contrast to C3, TEP1 is secreted into hemolymph as
a single chain molecule. The cleavage of TEP1 in the protease-
sensitive region is functionally reminiscent of the intracellular
maturation of C3: in both cases, the cleaved products remain
associated to form a two-chain molecule, which retains the
intact internal thioester bond. In the case of TEP1, however,
this maturation takes place in the hemolymph and not intracellu-
larly. The cleavage is brought about by as yet unknown secreted
protease(s), which cleave(s) TEP1 within the 20-amino-acid
protease-sensitive region. Therefore, the crystal structure of
TEP1r may indeed represent a proform as has been suggested
(Gros et al., 2008). It is presently unclear how activation of mature
TEP1 is achieved and whether, similarly to C3, an additional
cleavage is required for this process.
The LRR protein-deficient model provides an excellent tool to
dissect early stages of TEP1 activation. The correlation between
abolition of TEP1 binding to parasites and depletion of the
mature form of TEP1 from circulation suggests that full-length
TEP1, present in the hemolymph, requires maturation to adopt
binding capability. New tools are necessary, however, to firmly
establish in vivo that it is indeed the mature two-chain and not
the full-length form that binds to parasites and self-tissues.
Figure 7. Model for TEP1 Function in the Presence
and Absence of the LRIM1/APL1 Complex
TEP1, which has several potential cleavage sites, is
constitutively cleaved in the hemolymph by (an) as yet
unknown protease(s). The processing generates TEP1-N
and TEP1-C fragments, which remain associated as two
chains. The mature form of TEP1 is maintained in circula-
tion by a complex composed of the LRR proteins LRIM1
and APL1 (the complex stoichiometry is not considered).
During infection with P. berghei, the LRR complex is dis-
placed from TEP1, which binds to the parasites and
promotes their killing. When LRR-encoding genes are
silenced by RNAi, mature TEP1 is depleted from circula-
tion by deposition on self-tissues before it could bind
parasites.
TEP1 is maintained in circulation by interac-
tion with LRIM1 and APL1. If either of the LRR
proteins is removed, the cleaved form of TEP1
disappears from circulation, and massive depo-
sition of TEP1 on self-tissues is detected, sug-
gesting that LRR proteins prevent binding of
the mature molecule to nearby surfaces. The
observation that, in the absence of LRRs,
TEP1 binds to self-surfaces before Plasmodium
infection suggests the mosquito origin of TEP1
activators. A number of mammalian comple-
ment control proteins that shape binding spec-
ificities of complement factors have been iden-
tified (Liszewski et al., 1996), and here we
implicate LRR proteins in this process. The role of LRR proteins
revealed by this study might be also relevant for regulation of
complement factors in other organisms.
Results presented here lead us to propose the following model
of TEP1 activation (Figure 7). TEP1 is constantly cleaved in the
hemolymph by (an) as yet unknown endogenous protease(s),
producing a mature cleaved molecule. Our structural and
biochemical studies in vitro strongly suggest that the N- and
C-terminal fragments do not dissociate after cleavage due to:
(1) the MG6 domain, which comprises b strands from both N
and C chains, and (2) the tight packing of MG7/MG8 to the other
MG domains (Baxter et al., 2007).
Mature TEP1 readily binds nearby surfaces and becomes
depleted from circulation unless it is stabilized by interaction
with at least two LRR proteins. LRIM1 and APL1 circulate in
the hemolymph and bind TEP1 before or shortly after its pro-
teolytic cleavage. It is currently unclear how the LRR proteins
interact. This could be achieved via heterodimerization of LRR
domains, as is the case of Toll and Toll-like receptors. Alterna-
tively, their predicted C-terminal coiled-coil motifs may asso-
ciate with each other to form homo- or heterodimers. Still,
whether the two LRR proteins form a complex and its molecular
composition remain to be elucidated. How TEP1 is targeted to
the parasite surface also requires clarification. A possible mech-
anism could be through displacement of the LRR proteins from
TEP1 as a result of direct or indirect interaction of LRR proteins
with (a) parasite protein(s) or by their proteolytic degradation.
Thus, LRR proteins might play a dual role in the process: (1) as
Cell Host & Microbe 5, 273–284, March 19, 2009 ª2009 Elsevier Inc. 281
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tion of TEP1 and (2) as recognition or guard molecules that
control TEP1 binding to pathogens. Our model further supports
the recently established concept of basal immunity inA. gambiae
(Frolet et al., 2006). Indeed, the function of LRIM1 and APL1 is
required prior to infection to maintain an appropriate level of
mature TEP1 in circulation.
Taken together, these data integrate previously identified
players into one major pathway employed by mosquitoes to
reduce the burden of Plasmodium infection and provide insights
into the regulation of TEP1 attachment to the parasites. All
refractory phenotypes described to date exhibit faster TEP1
binding and complete Plasmodium killing at the very early time
points of infection (Blandin et al., 2004; Frolet et al., 2006).
Further dissection of molecular mechanisms that govern effi-
ciency of TEP1 deposition on the parasite surface will be an
asset for design of novel strategies for vector control based on
modulation of the mosquito immune defense. Importantly, this
defense appears to be relevant not only for the rodent malaria
model used in this study, but also for human malaria parasites.
EXPERIMENTAL PROCEDURES
Mosquito Rearing and Parasite Infections
A. gambiaeG3 (S) and L3-5 (R) strains were maintained at 28C and 70%–80%
humidity in a 12/12 hr day/night cycle. For infection experiments, mosquitoes
were fed on anesthetized CD1 mice infected with the P. berghei GFP-con
259cl2 clone (ANKA strain) that constitutively expresses GFP (Franke-Fayard
et al., 2004). Unfed mosquitoes were removed from the samples. Parasitemia
in mice was assessed by Diff-Quick I- and II- (eosin G and thiazine dye, Dade
Behring) stained smears from tail blood for proportion of infected red blood
cells and gametocytes and/or by FACS analysis of GFP parasites.
DsRNA Synthesis and Injection
A fragment of APL1 and of APL2 was amplified by PCR from cDNA templates
of G3 mosquitoes using specific primer pairs and conditions reported earlier
(Riehle et al., 2006). The APL1 PCR product was cloned into the pGEM-T
Easy Vector and subcloned into pLL10 (Blandin et al., 2002) as a 613 bp EcoRI
fragment, resulting in pLL442. The APL2 PCR product was cloned into the
pGEM-T Easy Vector and subsequently cloned into pLL10 as an 882 bp EcoRI
insert, producing pLL444. Production of dsRNA was carried out as previously
reported (Frolet et al., 2006; Levashina et al., 2001).
For RNAi gene silencing, 1- to 2-day-old females were anesthetized on
a CO2 pad and injected with 138 nl of dslacZ or a mixture of two different
dsRNAs at a concentration of 3 mg/ml using a Nanoject II Injector (Drummond;
Broomall, PA). In order to inject the same quantity and volume of dsRNA while
performing single and double gene knockdowns, dsRNAs for single knock-
downs were mixed with dslacZ in a 1:1 proportion. For P. berghei infection
experiments, mosquitoes recovered for 3 days following injection before being
offered an infectious blood meal.
Phenotypic Analysis after dsRNA Injection
Immunoblotting
Hemolymph was collected in denaturing protein loading buffer (Tris-HCl
0.35 M, SDS 10.3%, glycerol 36%, b-mercaptoethanol 5%, bromophenol
blue 0.012%) by proboscis clipping from 10 or 15 dsRNA-treated mosquitoes
at different time points after injection and/or infection. For whole-body
mosquito extracts, ten insects were ground in extraction buffer containing
20 mM HEPES pH 7.5, 1 M NaCl, and a protease inhibitor cocktail (Complete
Mini, Roche). Debris and lipids were removed by centrifugation. Hemolymph
and whole-body extracts were denatured in protein loading buffer at 65C
for 5 min. Samples were separated by 7% SDS-PAGE. Protein membrane
transfer, antibody incubations, and detection were carried out as previously
described (Levashina et al., 2001).282 Cell Host & Microbe 5, 273–284, March 19, 2009 ª2009 ElsevieImmunofluorescence Analysis
Mosquito midguts and abdominal epidermis were dissected on ice, fixed in
4% formaldehyde, washed with PBS, and incubated with affinity-purified
rabbit polyclonal anti-TEP1-C antibody (1/300) (Levashina et al., 2001) and/
or mouse monoclonal anti-TEP1-N antibody (1/20). Secondary fluorescence-
labeled antibodies (Cy3 or Alexa546, Alexa488, Cy5) were used at a dilution
of 1/1000 (Jackson Laboratory; Bar Harbor, ME). Tissues were mounted in
DAPI-containing Vectashield medium (Vector Laboratories, Inc.; Burlingame,
CA) and monitored using an Axiovert 200M fluorescence microscope (Zeiss)
equipped with an Apotome module (Zeiss). Images of 6–12 optical sections
were created, and captures were reconstructed and analyzed using the Axio-
Vision 4.6 software (Zeiss).
Quantitative Real-Time PCR
Total RNA from ten mosquitoes was extracted with TRIzol reagent (Invitrogen)
and treated with DNase I (Ambion; Austin, TX) according to the suppliers’
instructions. Total RNA (2 mg) was converted to cDNA using the M-MLV
Reverse Transcriptase (Invitrogen) and random hexamers (Invitrogen). Quanti-
tative PCR reactions were run on a 7500 Fast Real-Time PCR instrument
(Applied Biosystems) using the TaqMan Fast Universal PCR Master Mix
(Applied Biosystems) according to the manufacturer’s instructions. For
LRIM1 (AGAP006348) and APL1 (AGAP007033), the PCR reactions were
assembled using the ABsolute QPCR SYBR Low ROX mix (Thermo Scientific).
Primers and probes were designed with the Primer Express software (Applied
Biosystems). The ribosomal protein transcript RpL19 (AGAP004422) was used
as an internal control in all the experiments. Data was analyzed with the Fast
Real-Time PCR software (Applied Biosystems).
TEP1: AG486 forward primer 50-ATACGGATCTCAGCTATACCAAATCG-30
AG487 reverse primer 50-TGCGGGCCTTTATGAGAAAA-30
TaqMan probe 50-FAM-TCCGAAGGTTGGTGTTC-MGB-30
RpL19: AG490 forward primer 50-CCAACTCGCGACAAAACATTC-30
AG491 reverse primer 50-ACCGGCTTCTTGATGATCAGA-30
TaqMan probe 50-VIC-CAAACTGATCAAGGATG-MGB-30
LRIM1: AG866 forward primer 50-AACGGACAGCAGCCTAAAGC-30
AG867 reverse primer 50-AGATCAAGCTCCTTTACGTTCCA-30
APL1: AG868 forward primer 50-CGACAGCCCGAATACAAATGC-30
AG869 reverse primer 50-GCACATCGTAGAACACACAGTCGTA-30
Antibody Production and Purification
Monoclonal Mouse Anti-TEP1-N Antibodies
Monoclonal antibodies were raised against a 6.8 kDa fragment corresponding
to the residues 337–398 of the full-length secreted protein: TPAKGITGK
VEVSDVGFETTTTSDNDGLIKLELQPSEGTEQLGINFNAVDGFFFYEDVNKVET.
This fragment bears four substitutions that differ between TEP1 from the G3
and L3-5 mosquito strains. The corresponding 206 bp fragment was amplified
from pLL3 (Levashina et al., 2001) using forward primer 50-CCATGGGAA
CACCGGCTAAAGGCATTAC-30, reverse primer 50-GGTACCTTACGTTTCTAC
CTTATTCACATCTTCATA-30, and standard PCR conditions. The amplified
product was first cloned into pCR2.1 TOPO (Invitrogen) and then subcloned
as a 204 bp NcoI-KpnI fragment into pETM11 derived from pET24d (Novagen).
The His-tagged peptide was produced in E. coli BL21 (DH3) with chaperones
using the two-step system (de Marco, 2007) and purified by immobilized
metal-affinity chromatography. Hybridoma cells producing antibodies against
the peptide were produced by the European Molecular Biology Laboratory
(Heidelberg, Germany) monoclonal antibody facility and subcloned twice to
reach monoclonality. Twenty-times-diluted conditioned medium from clone
E1D6 was used for immunoblotting and immunofluorescence analysis.
Polyclonal Rabbit Antibodies Directed Against LRIM1,
APL1, and PPO2
For protein expression, the coding sequences of LRIM1, APL1, and PPO2
were cloned into expression vectors using the Gateway Cloning technology
(Invitrogen). LRIM1, APL1, and PPO2 were amplified by PCR from clones of
a Gateway cDNA immune library (S. Wyder, S.-H. Shiao, S.A.B., C. Kappler,
C.F., N. Baldeck, J.A.H., and E.A.L., unpublished data) (clones 11DF10,
104AF09, and 53BA04, respectively) using the primers listed below. PCR
products were cloned by recombination into the entry vector pDONR221
(resulting in pLL462, pLL468, and pLL466, respectively). Inserts were then
subcloned by recombination into the expression vector pDEST17 (pLL463,
pLL469, and pLL467, respectively).r Inc.
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GGCTTCCAGGCGTGCCAAGTCGTC-30
AG723 reverse primer 50-GGGGACCACTTTGTACAAGAAAGCTGGGTCC
TACAGCTGGCTCGCTAAATTCTG-30
APL1: AG765 forward primer 50-GGGGACAAGTTTGTACAAAAAAGCAGG
CTTCAATTATTGGTATACGGAAGAGCAG-30
AG766 reverse primer 50-GGGGACCACTTTGTACAAGAAAGCTGGGTC
CTATGCGCATAGACCTAACGC-30
PPO2: AG724 forward primer 50-GGGGACAAGTTTGTACAAAAAAGCAG
GCTTCAACAATATCTTGGCCCTGTTGC-30
AG735 reverse primer 50- GGGGACCACTTTGTACAAGAAAGCTGGGTC
CTACGTGGCCGTCTTCATGTTC
LRIM1 (pLL463), APL1 (pLL469), and PPO2 (pLL467) were expressed in the
E. coliBL21-AI strain at 37C for 4–6 hr as insoluble His-tagged proteins. Inclu-
sion bodies were purified from bacteria using the B-PER II Bacterial Protein
Extraction Reagent (Pierce) according to the manufacturer’s instructions. After
separation of 300 mg of inclusion bodies on a single-slot SDS-PAGE, the gel
band containing the recombinant protein was excised, homogenized, and in-
jected into a rabbit for immunization. One month later, rabbits were challenged
with three subsequent boosts of 150 mg of isolated inclusion bodies at intervals
of 2 weeks and bled after each boost. A small volume of the final bleed serum
for LRIM1 and APL1 was purified by an adapted small-scale affinity purification
method (Smith and Fisher, 1984). For immunoblotting experiments, purified
anti-LRIM1 and anti-APL1 antibodies were used at a dilution of 1/500. Anti-
PPO2 serum was used at a dilution of 1/20,000.
Protein Purification and Limited Proteolysis
TEP1r-63His was cloned, expressed, and purified as previously described
(Baxter et al., 2007). Large-scale trypsinolysis of TEP1r-63His was performed
using bovine pancreatic trypsin (Sigma) at a 1:20 molar ratio to TEP1 in 0.2 M
NaCl and 20 mM HEPES pH 7.5. Samples were incubated for 5 min at 37C,
then placed on ice and diluted 2-fold with 20 mM HEPES pH 7.5, 0.2 mM Leu-
peptin hemisulfate (Sigma), and 0.2 mM soybean trypsin-chymotrypsin inhib-
itor. Samples were immediately repurified on a Superdex 200 10/30 size exclu-
sion column or Mono S 5/50 cation exchange column (GE Healthcare). Limited
proteolysis on small scales was performed with trypsin, chymotrypsin, V8
protease, and elastase using similar buffer and incubation conditions but
stopped by addition of 500 mM Pefabloc (Fluka; Buchs SG, Switzerland) fol-
lowed directly by SDS-PAGE using Novex 4%–20% precast gels.
Thioester Assay
For each sample, two aliquots of 15 ml were mixed with 4 ml 53 Laemmli buffer
without reducing agent. Following the addition of 1 ml 1 M DTT, the control
sample () was incubated at room temperature for 15 min. The test sample
(+) was placed at 94C for 15 min, then cooled to room temperature prior to
addition of 1 ml 1 M DTT. SDS-PAGE was performed using Novex 4%–20%
precast gels.
Immunoprecipitation
One hundred fifty to two hundred female mosquitoes were anesthetized with
CO2 and injected with 69 nl of TEP1r-63His (2.5 mg/ml in PBS) or with PBS
alone using a Nanoject II Injector (Drummond). Mosquitoes were left for 3 hr
and next homogenized in 1 ml IP buffer composed of Tris 50 mM pH 7.9,
NaCl 100 mM, EDTA 2 mM, BSA 0.1 mg/ml, Tween 20 0.1%, and protease
inhibitors (Complete Mini, Roche). Lipids and debris were removed by several
rounds of centrifugation. For the following incubations, samples were kept at
4C under constant shaking. For preclearance, extracts were incubated for
1 hr with 30 ml of Protein A-Sepharose beads slurry (GE Healthcare). Superna-
tant was next incubated for 1 hr with 1 mg anti-C-terminal 63His-tag antibody
(Invitrogen) and subsequently with 30 ml of Protein A-Sepharose slurry for
another hour. Samples were centrifuged, and post-IP supernatant was
collected. Sepharose beads were washed several times, alternating Tris-HCl
50 mM pH 7.9 Tween 20 0.1% and Tris-HCl 50 mM pH 7.9 Tween 20 0.1%
NaCl 500 mM buffers. Antibodies and bound proteins were eluted from the
beads in 40 ml protein loading buffer at 95C for 3 min. Aliquots of post-IP
supernatant and eluates were separated by 7% SDS-PAGE. Immunoblotting
was performed as previously reported (Levashina et al., 2001).Cell HSUPPLEMENTAL DATA
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